AI assistant
HEALTHEQUITY, INC. — Director's Dealing 2017
Apr 5, 2017
30722_dirs_2017-04-05_243ca9d3-6d8a-49f2-9ae4-d0956f59092e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2017-04-03
Reporting Person: Kessler Jon (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-04-03 | Common Stock | M | 20000 | $1.25 | Acquired | 440000 | Direct |
| 2017-04-03 | Common Stock | S | 20000 | $41.8534 | Disposed | 420000 | Direct |
| 2017-04-04 | Common Stock | M | 10000 | $1.25 | Acquired | 430000 | Direct |
| 2017-04-04 | Common Stock | S | 10000 | $43.0104 | Disposed | 420000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-04-03 | Stock Option (right to buy) | $1.25 | M | 20000 | Disposed | 2021-08-08 | Common Stock (20000) | Direct |
| 2017-04-04 | Stock Option (right to buy) | $1.25 | M | 10000 | Disposed | 2021-08-08 | Common Stock (10000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $41.28 | 2027-03-27 | Common Stock (69639) | 69639 | Direct |
| Stock Option (right to buy) | $14 | 2024-07-30 | Common Stock (120000) | 120000 | Direct |
Footnotes
F1: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.52 to $42.43, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.95 to $43.14, inclusive.
F4: The option is immediately exercisable.
F5: The option becomes exercisable as to 17,409 shares on March 27, 2018 and in three annual installments of 17,410 shares on March 27, 2019, 2020 and 2021.